HAEMONETICS CORP Quarterly Accumulated Other Comprehensive Income (Loss), Net of Tax in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
Summary
Haemonetics Corp quarterly Accumulated Other Comprehensive Income (Loss), Net of Tax history and growth rate from Q1 2010 to Q3 2024.
  • Haemonetics Corp Accumulated Other Comprehensive Income (Loss), Net of Tax for the quarter ending September 28, 2024 was -$34.6M, a 5.68% decline year-over-year.
Accumulated Other Comprehensive Income (Loss), Net of Tax, Quarterly (USD)
Accumulated Other Comprehensive Income (Loss), Net of Tax, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 -$34.6M -$1.86M -5.68% Sep 28, 2024 10-Q 2024-11-07
Q2 2024 -$42.7M -$13.1M -44.5% Jun 29, 2024 10-Q 2024-08-08
Q1 2024 -$35.6M -$5.25M -17.3% Mar 30, 2024 10-Q 2024-11-07
Q4 2023 -$24.4M +$11.4M +31.9% Dec 30, 2023 10-Q 2024-02-08
Q3 2023 -$32.7M +$7.55M +18.8% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$29.5M +$3.2M +9.78% Jul 1, 2023 10-Q 2023-08-08
Q1 2023 -$30.4M -$4.43M -17.1% Apr 1, 2023 10-K 2024-05-20
Q4 2022 -$35.8M -$6.45M -22% Dec 31, 2022 10-Q 2023-02-07
Q3 2022 -$40.3M -$10.7M -36.3% Oct 1, 2022 10-Q 2022-11-08
Q2 2022 -$32.7M -$3.62M -12.4% Jul 2, 2022 10-Q 2022-08-10
Q1 2022 -$26M +$3.59M +12.2% Apr 2, 2022 10-K 2024-05-20
Q4 2021 -$29.3M +$509K +1.71% Jan 1, 2022 10-Q 2022-02-08
Q3 2021 -$29.5M +$8.94M +23.2% Oct 2, 2021 10-Q 2021-11-09
Q2 2021 -$29.1M +$14.6M +33.4% Jul 3, 2021 10-Q 2021-08-11
Q1 2021 -$29.5M +$15.6M +34.5% Apr 3, 2021 10-K 2023-05-22
Q4 2020 -$29.9M +$3.85M +11.4% Dec 26, 2020 10-Q 2021-02-02
Q3 2020 -$38.5M -$2.37M -6.55% Sep 26, 2020 10-Q 2020-11-04
Q2 2020 -$43.7M -$9.71M -28.6% Jun 27, 2020 10-Q 2020-08-04
Q1 2020 -$45.1M -$14.8M -48.6% Mar 28, 2020 10-K 2022-05-25
Q4 2019 -$33.7M -$4.61M -15.8% Dec 28, 2019 10-Q 2020-02-04
Q3 2019 -$36.1M -$12.1M -50.2% Sep 28, 2019 10-Q 2019-11-01
Q2 2019 -$34M -$10.3M -43.4% Jun 29, 2019 10-Q 2019-08-06
Q1 2019 -$30.4M -$11.4M -60% Mar 30, 2019 10-K 2021-05-26
Q4 2018 -$29.1M -$1.88M -6.92% Dec 29, 2018 10-Q 2019-02-05
Q3 2018 -$24M +$3.38M +12.3% Sep 29, 2018 10-Q 2018-11-06
Q2 2018 -$23.7M +$5.53M +18.9% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 -$19M +$13.9M +42.2% Mar 31, 2018 10-K 2020-05-20
Q4 2017 -$27.2M +$11.8M +30.3% Dec 30, 2017 10-Q 2018-02-06
Q3 2017 -$27.4M +$9.31M +25.3% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 -$29.2M +$6.68M +18.6% Jul 1, 2017 10-Q 2017-08-07
Q1 2017 -$32.9M +$2.17M +6.18% Apr 1, 2017 10-K 2019-05-22
Q4 2016 -$39M +$2.32M +5.62% Dec 31, 2016 10-Q 2017-02-06
Q3 2016 -$36.7M +$1.76M +4.57% Oct 1, 2016 10-Q 2016-11-07
Q2 2016 -$35.9M -$11.8M -49.2% Jul 2, 2016 10-Q 2016-08-01
Q1 2016 -$35M -$13.3M -61.3% Apr 2, 2016 10-K 2018-05-23
Q4 2015 -$41.3M -$33.8M -446% Dec 26, 2015 10-Q 2016-02-02
Q3 2015 -$38.5M -$38.5M -58392% Sep 26, 2015 10-Q 2015-11-04
Q2 2015 -$24.1M -$24.6M -4363% Jun 27, 2015 10-Q 2015-07-30
Q1 2015 -$21.7M -$23.1M -1641% Mar 28, 2015 10-K 2017-05-24
Q4 2014 -$7.58M -$12.5M -254% Dec 27, 2014 10-Q 2015-02-05
Q3 2014 $66K -$3.87M -98.3% Sep 27, 2014 10-Q 2014-11-04
Q2 2014 $565K -$4.61M -89.1% Jun 28, 2014 10-Q 2014-07-31
Q1 2014 $1.41M -$4.02M -74% Mar 29, 2014 10-K 2016-06-01
Q4 2013 $4.93M -$1.96M -28.4% Dec 28, 2013 10-Q 2014-01-30
Q3 2013 $3.93M -$624K -13.7% Sep 28, 2013 10-Q 2013-10-30
Q2 2013 $5.17M -$67K -1.28% Jun 29, 2013 10-Q 2013-08-02
Q1 2013 $5.43M -$3.68M -40.4% Mar 30, 2013 10-K 2015-05-22
Q4 2012 $6.89M -$2.23M -24.4% Dec 29, 2012 10-Q 2013-02-01
Q3 2012 $4.56M -$4.23M -48.1% Sep 29, 2012 10-Q 2012-11-07
Q2 2012 $5.24M -$6.3M -54.6% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 $9.11M -$431K -4.52% Mar 31, 2012 10-K 2014-05-22
Q4 2011 $9.12M +$3.4M +59.4% Dec 31, 2011 10-Q 2012-02-06
Q3 2011 $8.79M +$3.62M +70.1% Oct 1, 2011 10-Q 2011-11-03
Q2 2011 $11.5M +$9.51M +469% Jul 2, 2011 10-Q 2011-08-10
Q1 2011 $9.54M +$3.64M +61.6% Apr 2, 2011 10-K 2013-05-20
Q4 2010 $5.72M Jan 1, 2011 10-Q 2011-02-08
Q3 2010 $5.17M Oct 2, 2010 10-Q 2010-11-10
Q2 2010 $2.03M Jul 3, 2010 10-Q 2010-08-11
Q1 2010 $5.91M Apr 3, 2010 10-K 2013-05-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.